1. Mahallawi WH, Khabour OF, Zhang Q, Makhdoum HM, Suliman BA. MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine 2018; 1(104): 8-13.

2. Wong C, Lam CW, Wu AK, Ip WK, Lee NL, Chan IH, et al. Plasma inflammatory cytokines and chemokines in severe acute respiratory syndrome. Clin. Exp. Immunol 2004; 136(1): 95-103.

3. Nabilpour M, Sadeghi A. Effect of Eight-Week Aerobic Moderate-Intensity Continuous Training on Il-1β and Il-13 Levels of Soleus Muscle Tissue in Male Diabetic Rats. IJDM 2021; 21(3): 129-138. [in Persian]

4. Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R. The COVID-19 cytokine storm; what we know so far. Front. immunol 2020; 11(3): 14-46.

5. Hall MW, Joshi I, Leal L, Ooi EE. Immune immunomodulation in coronavirus disease 2019 (COVID-19): strategic considerations for personalized therapeutic intervention. Clin. Infect. Dis 2022; 74(1): 144-148.

6. Shi Y, Wang Y, Shao C, Huang J, Gan J, Huang X, et al. COVID-19 infection: the perspectives on immune responses. Nature Publishing Group 2020; 27(5): 1451-1454.

7. Zaim S, Chong JH, Sankaranarayanan V, Harky A. COVID-19 and multiorgan response. Curr Probl Cardiol 2020; 45(8): 100618.

8. Noroozi R, Branicki W, Pyrc K, Łabaj PP, Pospiech E, Taheri M, et al. Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions. Cytokine 2020; 1(133): 155-143.

9. Titanji BK, Titanji BK, Farley MM, Mehta A, Connor-Schuler R, Moanna A, Cribbs SK, et al. Use of baricitinib in patients with moderate to severe coronavirus disease 2019. Clin. Infect. Dis 2021; 72(7): 1247-50.

10. Del Valle DM, Kim-Schulze S, Huang HH, Beckmann ND, Nirenberg S, Wang B, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat. Med 2020; 26(10): 1636-1643.

11. Seifi-Skishahr F, Nabilpour M. Introducing an Index to Predict Lung Involvement in Hypertensive Patients with COVID-19. JNKUMS 2022; 14 (3): 78-83. [in Persian]

12. Nabilpour M, Sadegi F. Comparison of some anthropometric and physiological indices of professional bodybuilding after recovery of Covid-19 disease and their clinical manifestations during exercise. Feyz 2021; 25(3): 970-977. [in Persian].

13. Ponti G, Maccaferri M, Ruini C, Tomasi A, Ozben T. Biomarkers associated with COVID-19 disease progression. Crit Rev Clin Lab Sci 2020; 57(6): 389-99.

14. Mandel M, Harari G, Gurevich M, Achiron A. Cytokine prediction of mortality in COVID19 patients. Cytokine 2020; 134(4): 155-190.

15. [15] Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020; 46(5): 846-848.

16. [16] Chen X, Zhao B, Qu Y, Chen Y, Xiong J, Feng Y, et al. Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely correlated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin. Infect. Dis 2020; 71(8):1937-1942

17. [17] McElvaney OJ, McElvaney OJ, Hobbs BD, Qiao D, McElvaney OF, Moll M, McEvoy NL, Clarke J, et al. A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19. EBioMedicine 2020; 1(61): 103026.

18. [18] Kara M, Ekiz T, Ricci V, Kara Ö, Chang KV, Özçakar L. ‘Scientific Strabismus’ or two related pandemics: coronavirus disease and vitamin D deficiency. Br J Nutr 2020; 124(7): 736-741.

19. [19] Motavari M, Skishahr FS, Nabilpour M, Mayhew J, Mamshali E, Afroundeh R. The Effect of Vitamin D Supplementation After Resistance Training on Physiological Characteristics in Futsal Players with Vitamin D Deficiency. Int J Sports Sci 2022; 5(1): 126610.

20. [20] Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab 2011; 96(1): 53-58.

21. [21] Lee JY, TY So, Thackray J. A review on vitamin d deficiency treatment in pediatric patients. J Pediatr Pharmacol Ther 2013; 18(4): 277-291.

22. [22] Lee MD, Lin CH, Lei WT, Chang HY, Lee HC, Yeung CY, et al. Does vitamin D deficiency affect the immunogenic responses to influenza vaccination? A systematic review and meta-analysis. Nutrients2018; 10(4): 409.

23. [23] Christakos S, Ajibade DV, Dhawan P, Fechner AJ, Mady LJ. Vitamin D: metabolism. Rheumatic Dis Clin 2012; 38(1): 1-1.

24. [24] Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: a systematic review and meta‐analysis. Rev Med Virol 2020; 30(6): 1-9.

25. [25] Jones SA, Hunter CA. Is IL-6 a key cytokine target for therapy in COVID-19? Nat Rev Immunol 2021; 21(6): 337-339.

26. [26] Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395(10223): 497-506.

27. [27] Lu L, Zhang H, Dauphars DJ, He YW. A potential role of interleukin 10 in COVID-19 pathogenesis. Trends Immunol 2021; 42(1): 3-5.

28. [28] Nabilpour M, Sadegi A, Faal Pakdeh M. The effect of two months of continuous exercise with chia (Salvia hispanica L.) supplement on the Internet-1 and 13 in Wistar diabetes rankings. Feyz 2021; 25(4): 1047-54. [in Persian]

29. Li H, Liu L, Zhang D, Xu J, Dai H, Tang N, Su X. SARS-CoV-2 and viral sepsis: observations and hypotheses. Lancet 2020; 395(10235): 1517-20.

30. Han H, Ma Q, Li C, Liu R, Zhao L, Wang W, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect 2020; 19 (1): 1123-30.

31. Jafari A, jahani M, Nabilpour M. The effect of aerobic exercise combined with supplementation of L-arginine on the response of C-reactive protein in obese men. J Appl Sport Psychol 2016; 3(2): 17-23. [in Persian]

32. Zhao Y, Qin L, Zhang P, Li K, Liang L, Sun J, et al. Longitudinal COVID-19 profiling associates IL-1RA and IL-10 with disease severity and with mild disease. JCI Insight 2020; 7: 5(13).

33. Dhar SK, Vishnupriyan K, Damodar S, Gujar S, Das M. IL-6 and IL-10 as predictors of disease severity in COVID-19 patients: results from meta-analysis and regression. Heliyon 2021; 7(2): e06155.

34. Luo X, Liao Q, Shen Y, Li H, Cheng L. Vitamin D deficiency is associated with COVID-19 incidence and disease severity in Chinese people. J Nutr 2021; 151(1): 98-103.

35. Grant WB, Lahore H, McDonnell SL, Baggerly CA, French CB, Aliano JL, et al. Evidence that vitamin D supplementation could reduce risk of influenza and COVID-19 infections and deaths. Nutrients 2020; 12(4): 988.

36. Komatsuzawa H, Ouhara K, Yamada S, Fujiwara T, Sayama K, Hashimoto K, et al. Innate defences against methicillin‐resistant Staphylococcus aureus (MRSA) infection. J Pathol 2006; 208(2): 249-260.

37. Klotman ME, Chang TL. Defensins in innate antiviral immunity. Nat Rev Immunol 2006; 6(6): 447-56.

38. Schwalfenberg GK, A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol Nutr Food Res 2011; 55(1): 96-108.

39. Rondanelli M, Miccono A, Lamburghini S, Avanzato I, Riva A, Allegrini P, et al. Self-care for common colds: the pivotal role of vitamin D, vitamin C, zinc, and echinacea in three main immune interactive clusters (physical barriers, innate and adaptive immunity) involved during an episode of common colds—practical advice on dosages and on the time to take these nutrients/botanicals in order to prevent or treat common colds. J Evid Based Complementary Altern Med 2018; 9(2018): 5813095.

40. Bouillon R, Garmyn M, Verstuyf A, Segaert S, Casteels K, Mathieu C. Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. Eur J Endocrinol 1995; 133(1): 7-16.